Let's empower the Type 2 Diabetes (T2D) community, specially low-income populations, to make life-style changes in their nutrition.
Half of American adults have one or more preventable, diet-related chronic disease. Our first market, Type 2 Diabetes (T2D) patients, need a life-style change in their entire's family's nutrition to be able to sustain a healthy diet in the long term. Today, they lack the right tools to be empowered and educated on how to make daily nutrition choices for their family. This is a problem for providers and payers too, as they struggle to make interventions between patient’s visits to the doctor.
Our technology educates consumers at every food purchase. We do this by asking them to take pictures of their grocery receipts and we turn them into nutrition information, recommendations, and goals. Our approach moves away from the “meal-logging” mentality, as it’s both time-consuming and not long-lasting. A permanent diet change depends in adjusting the entire family’s habits. For providers, we enable them to monitor and proactively intervene patient's nutrition in between hospital visits.
We are working with a number of partners, such as health care providers, grocery stores, government, insurance, among other institutions to make this vision a reality.
What are the key outcomes and impact of your solution?
Our goal is to impact the health of diet-related chronic patients. In the next 5 years, we will focus on Type 2 Diabetes (T2D), where 30M people in the US suffer from this disease. The cost to treat T2D in the US is $300 Billion, creating a huge burden to the Healtcare system.
Our measurable goal, is to impact A1C and BMI levels for Type 2 Diabetes. We are currently working with providers, such as a large hospital in Boston to have biometric data and improve A1C levels at least by 0.5% for every patient.
So far, we have measured success with more than 100 users, by looking at their progression on healthy food purchases. Our users, on average have increase vegetable purchases by 30% and fats reduced by 15%, which should reflect on improvements in their A1C and BMI levels. This is why we are now moving forward with Phase 2 of our metrics by analyzing these 2 components.
What actions do you propose to realize your stated goals?
So far, we are working on partnerships with providers, payers, and government. Our goal is to reach our end users (T2D patients) through partnerships with Hospitals and Insurance companies. They already have a population of patients that need this service, and are already receiving care from their providers. We are working with them so that we can integrate our technology into their existing processes, providing a valuable tool to their patients so that they can take charge of their nutrition. Our technology not only provides real-time recommendations and advice to the end users, but also provides information to their doctors about what their patients eat, so they can provide better advice.
Our pilot programs have worked with +100 end users and we have received positive feedback from them, as it's the first time that they really understand what is in their shopping bag as it relates to nutrition. We have seen and measured behavior change on our pilot study, and have reported +30% increase in vegetable consumption and a 15% overall decrease in fat. Our next step is translating this into improvements in health metrics such as A1C and BMI levels on a clinical setting.
Who will take these actions?
Payers: Insurance companies have a strong financial incentive to improve the health of their members, specially Type 2 Diabetes. They pay a key role as they are the "economic buyers" of our product
Providers: They play a key role as they are the direct interaction with the patients. We need to collaborate closely with them, so that together we can provide the tools and advice necessary for Type 2 Diabetes community to make life-style changes in their nutrition.
Government: Has a unique access to the low-income population, which is where we are primarily targeting our technology. They are the population that needs nutrition education the most. In addition, government plays a key role on legislation, as it is important that it continues to move in the direction on preventive care.
Our target population is low income that has pre diabetes or Type 2 Diabetes. We are starting in the US, working locally with urban cities across the country. Our 10 year plan is to expand to other countries such as Mexico, South America, and other countries where obsesity and diabetes prevails.
What do you expect are the costs associated with piloting and implementing the solution, and what is your business model?
For Prototype/ Piloting phase, we need funds ($150-$200K) to expand our clinical study. With the clinical validation that our product affects A1C and BMI levels, we will move to formalize partnerships with providers and payers (2-5 years). Our solution is a for-profit, and we will generate funds by having payers (insurance companies) reimbursing the cost of our service that will be used by patients at hospitals.
Our solution, as we are tech-enabled, is scalable not only inside the US but abroad.
We are currently piloting our product outside a clinical setting so that we can get constant interaction with the end user. We have seen very positive results from that interaction.
In parallel, we are working with a Hospital in Boston on a clinical study that will validate clinically the health outcomes of our intervention, such BMI and A1C levels.
Once the clinical validation is done, we will work with payers and providers to scale our business.
There is a Solution called Food, where they are trying to understand the relationship with food and health. This is also a component of the challenge we are trying to solve.
How can we help people prevent, detect and manage chronic diseases, especially in resources-limited settings?